ANDA 40102, held by Pharmobedient. Methazolamide.
As of Nov 15, 2026, ANDA 40102 (Methazolamide), held by Pharmobedient, was first approved by FDA on Aug 28, 1996, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 28, 1996 | Original application | Approved | None posted |
| Methazolamide25MG · tablet;oral | Methazolamide | Discontinued |
| Methazolamide50MG · tablet;oral | Methazolamide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
